Birmingham · United KingdomInvestor & Chief Executive

AddamSattar

Chief executive of BioWaste Solutions Group. He was Head of Key Accounts at Sweden & Martina. That role is finished. Today he takes trading and business consultations, and runs a private signals group.

Based in Birmingham, serving the UK The record
Scroll
Addam Sattar in black, beside a black Lamborghini at the door of a house
Birmingham · United Kingdom

Experience across

BMW · Sytner Baldan Group Sweden & MartinaPast role BioWaste Solutions Group

Directory

The directory.

Six ways in. Telegram is the profitable group — signals and the course share one invitation. The company, the career, and the office sit beside it. The channels, in full.

Private time

One hour.
£150.

A consultation, a trading session, or a strategy hour. You choose the length. The desk confirms the time, then takes payment at £150 an hour.

  • Trading mentorship
  • Private consultation
  • Strategy session
  • By video, or in Birmingham
  • BioWaste quotes stay free — this rate is for Addam’s time
Open the booking desk
Addam Sattar in a rooftop pool in Dubai, with the Burj Al Arab behind him
Dubai A line he returns to.

The record

Fifteen years
in front of the client.

The goal isn't to be busy.
The goal is to be free.

The roles, the figures, and the years are written once, on their own page. Sweden & Martina was the chapter before this one.

His words

Lines he stands by.

Published by him. The company, the hour, and the group are how he spends the freedom.

The goal isn't to be busy. The goal is to be free.

A line he returns to

Keep showing up. Keep believing. Keep progressing.

On building BioWaste

The goal isn't to be better than anyone else. The goal is to be better than you were yesterday.

The same standard

Correspondence

Write to the office.

Enquiries for BioWaste, press, or partnerships. Trading questions belong in the community.

Replies come from the office — usually within one working day.

Your details are used to respond to your enquiry. Please do not include patient, medical, or sensitive financial information.